跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APO-ALENDRONATE 70MG TABLET - HSA Drug Approval Details
Approvals
/
HSA
/
APO-ALENDRONATE 70MG TABLET
Approved
THERAPEUTIC
APO-ALENDRONATE 70MG TABLET
APOTEX INC (CANADA)
🇸🇬 Health Sciences Authority
Approval Date
Nov 12, 2010
Approval ID
afb65fb2b8dbc393
Company
APOTEX INC (CANADA)
Type
Therapeutic
Approval Details
Approval Id
afb65fb2b8dbc393
Drug Name
APO-ALENDRONATE 70MG TABLET
Product Name
APO-ALENDRONATE 70MG TABLET
Approval Number
SIN13882P
Approval Date
2010-11-12
Registrant
PHARMAFORTE SINGAPORE PTE LTD
Licence Holder
PHARMAFORTE SINGAPORE PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
TABLET
Route Of Administration
ORAL
Atc Code
M05BA04
Atc Item Name
alendronic acid
Pharma Manufacturer Name
PHARMAFORTE SINGAPORE PTE LTD
Active Ingredients
Alendronate (eqv Alendronate Sodium Trihydate 91.35mg)
70.0 mg
ALENDRONATE (EQV ALENDRONATE SODIUM TRIHYDATE 91.35 MG)
70 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Nov 12, 2010
Approval ID
afb65fb2b8dbc393
Type
Therapeutic
Back to HSA Approvals